Anbio Biotechnology NNNN
NASDAQ NNNN
$3.81 +0.10 (+2.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Anbio Biotechnology (NNNN) Other Accumulated Expenses (2023 - 2025)

Updated

Anbio Biotechnology (NNNN) reported Other Accumulated Expenses of $87,836 for the quarter ended Dec 31, 2025, down 16.3% from $104,979 a year earlier.

Analysis

Anbio Biotechnology (NNNN) Other Accumulated Expenses (2023 - 2025) Analysis & Trends

Dating back to the quarter ended Dec 31, 2023, Anbio Biotechnology's Other Accumulated Expenses record includes 4 quarters.

  • By year, Other Accumulated Expenses came in at $104,979 in the year ended Dec 31, 2024 (-36.7%) and $165,909 in the year ended Dec 31, 2023.
  • Five-year quarterly Other Accumulated Expenses spans a low of $70,777 in the quarter ended Jun 30, 2025 and a high of $165,909 in the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Anbio Biotechnology 162.02 Mn 115.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 87,836.00
Jun 30, 2025 70,777.00
Dec 31, 2024 104,979.00
Dec 31, 2023 165,909.00
API Access

Anbio Biotechnology Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NNNN&period=max&api_key=YOUR_API_KEY